The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Small Intestinal Bacterial Overgrowth: Diagnosis and Treatment
Abstract
Small intestinal bacterial overgrowth (SIBO) is a clinical condition characterized by a malabsorption syndrome due to an increase in microorganisms within the small intestine. The main mechanisms restricting bacterial colonization in the upper gut are the gastric acid barrier, mucosal and systemic immunity and intestinal clearance. When these mechanisms fail, bacterial overgrowth develops. Diarrhea, steatorrhea, chronic abdominal pain, bloating and flatulence are common symptoms and are similar to those observed in irritable bowel syndrome. Breath tests (glucose and/or lactulose breath tests) have been proposed as a sensitive and simple tool for the diagnosis of bacterial overgrowth, being non-invasive and inexpensive compared to the gold standard represented by the culture of intestinal aspirates. Antibiotic therapy is the cornerstone of SIBO treatment. Current SIBO treatment is based on empirical courses of broad-spectrum antibiotics since few controlled studies concerning the choice and duration of antibiotic therapy are available at present.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Small Intestinal Bacterial Overgrowth: A Framework for Understanding Irritable Bowel Syndrome
Lin, H. C. (2004) · JAMA · doi:10.1001/jama.292.7.852 · Cited by 396
Romagnuolo, J., Schiller, D., & Bailey, R. J. (2002) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2002.05664.x · Cited by 283
Cited by
Small intestinal bacterial overgrowth syndrome
Bures, J. (2010) · World Journal of Gastroenterology · doi:10.3748/wjg.v16.i24.2978 · Cited by 620
Kowal-Bielecka, O., Landewé, R., Avouac, J., Chwiesko, S., Miniati, I., Czirjak, L., Clements, P., Denton, C., Farge, D., Fligelstone, K., et al. (2009) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.096677 · Cited by 619
Intestinal dysbiosis and lowered serum lipopolysaccharide-binding protein in Parkinson's disease
Hasegawa, S., Goto, S., Tsuji, H., Okuno, T., Asahara, T., Nomoto, K., Shibata, A., Fujisawa, Y., Minato, T., Okamoto, A., et al. (2015) · PLOS ONE · doi:10.1371/journal.pone.0142164 · Cited by 523
“Another intestinal abnormality in PD is small intestinal bacterial overgrowth (SIBO), where the bacterial density of small intestine is above 10(5) colony-forming units/ml and the colonic bacterial species are present in the small intestine [33].”
BackgroundDysbiosis of gut microbiota and microbial metabolites in Parkinson's disease
Sun, M.-F., & Shen, Y.-Q. (2018) · Ageing Research Reviews · doi:10.1016/j.arr.2018.04.004 · Cited by 445
Increased Incidence of Small Intestinal Bacterial Overgrowth During Proton Pump Inhibitor Therapy
Lombardo, L., Foti, M., Ruggia, O., & Chiecchio, A. (2010) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2009.12.022 · Cited by 350
The role of small intestinal bacterial overgrowth in Parkinson's disease
Fasano, A., Bove, F., Gabrielli, M., Petracca, M., Zocco, M. A., Ragazzoni, E., Barbaro, F., Piano, C., Fortuna, S., Tortora, A., et al. (2013) · Movement Disorders · doi:10.1002/mds.25522 · Cited by 344
“Given the protective role of gastric acidity, this may be because the acid hyposecretion related to the atrophic gastritis caused by HP44 predisposes patients to SIBO.1 To the best of our knowledge, no other study has specifically addressed this issue, and it is also possible that some of the clinical consequences of…”
BackgroundMethodInfluentialSelf-citationTheis, V. S., Sripadam, R., Ramani, V., & Lal, S. (2010) · Clinical Oncology · doi:10.1016/j.clon.2009.10.003 · Cited by 268
The Gut-Brain Axis in Parkinson’s Disease: Possibilities for Food-Based Therapies
Perez-Pardo, P., Kliest, T., Dodiya, H. B., Broersen, L. M., Garssen, J., Keshavarzian, A., & Kraneveld, A. D. (2017) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2017.05.042 · Cited by 203
Hammer, H. F., Fox, M. R., Keller, J., Salvatore, S., Basilisco, G., Hammer, J., Lopetuso, L., Benninga, M., Borrelli, O., Dumitrascu, D., et al. (2022) · United European Gastroenterology Journal · doi:10.1002/ueg2.12133 · Cited by 189
The altered gut microbiota in adults with cystic fibrosis
Burke, D. G., Fouhy, F., Harrison, M. J., Rea, M. C., Cotter, P. D., O’Sullivan, O., Stanton, C., Hill, C., Shanahan, F., Plant, B. J., et al. (2017) · BMC Microbiology · doi:10.1186/s12866-017-0968-8 · Cited by 179
Prevalence of small intestinal bacterial overgrowth in Parkinson’s disease
Gabrielli, M., Bonazzi, P., Scarpellini, E., Bendia, E., Lauritano, E. C., Fasano, A., Ceravolo, M. G., Capecci, M., Rita Bentivoglio, A., Provinciali, L., et al. (2011) · Movement Disorders · doi:10.1002/mds.23566 · Cited by 175
Self-citationGrover, M., Kanazawa, M., Palsson, O. S., Chitkara, D. K., Gangarosa, L. M., Drossman, D. A., & Whitehead, W. E. (2008) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2008.01142.x · Cited by 111
Small intestinal transit time is delayed in small intestinal bacterial overgrowth
Roland, B. C., Ciarleglio, M. M., Clarke, J. O., Semler, J. R., Tomakin, E., Mullin, G. E., & Pasricha, P. J. (2015) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0000000000000257 · Cited by 101
Nuzum, N. D., Loughman, A., Szymlek-Gay, E. A., Hendy, A., Teo, W.-P., & Macpherson, H. (2020) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2020.02.003 · Cited by 103
The gut-brain axis and Parkinson disease: Clinical and pathogenetic relevance
Menozzi, E., Macnaughtan, J., & Schapira, A. H. V. (2021) · Annals of Medicine · doi:10.1080/07853890.2021.1890330 · Cited by 81
Gastrointestinal autonomic dysfunction in patients with Parkinson’s disease
Kim, J.-S., & Sung, H.-Y. (2015) · Journal of Movement Disorders · doi:10.14802/jmd.15008 · Cited by 76
Prevalence of small intestinal bacterial overgrowth in Chinese patients with Parkinson's disease
Niu, X.-L., Liu, L., Song, Z.-X., Li, Q., Wang, Z.-H., Zhang, J.-L., & Li, H.-H. (2016) · Journal of Neural Transmission · doi:10.1007/s00702-016-1612-8 · Cited by 64
MONTALTO, M., GALLO, A., SANTORO, L., D’ONOFRIO, F., CURIGLIANO, V., COVINO, M., CAMMAROTA, G., GRIECO, A., GASBARRINI, A., & GASBARRINI, G. (2008) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2008.03815.x · Cited by 63
Self-citationMarkers of bacterial translocation in end-stage liver disease
Koutsounas, I. (2015) · World Journal of Hepatology · doi:10.4254/wjh.v7.i20.2264 · Cited by 55
Rezaie, A., Nikfar, S., & Abdollahi, M. (2010) · Archives of Medical Science · doi:10.5114/aoms.2010.13507 · Cited by 40
“small intestinal bacterial overgrowth [SIBO]), it leads to various non-specific symptoms such as bloating, flatulence, abdominal pain and watery diarrhoea [8].”
BackgroundSmall intestinal bacterial overgrowth and intestinal permeability
Lauritano, E. C., Valenza, V., Sparano, L., Scarpellini, E., Gabrielli, M., Cazzato, A., Ferraro, P. M., & Gasbarrini, A. (2010) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365521.2010.485325 · Cited by 37
Self-citationThe effects and mechanism of action of methane on ileal motor function
Park, Y. M., Lee, Y. J., Hussain, Z., Lee, Y. H., & Park, H. (2017) · Neurogastroenterology & Motility · doi:10.1111/nmo.13077 · Cited by 27
Metadata
- Authors
- Gasbarrini, A., Lauritano, E. C., Gabrielli, M., Scarpellini, E., Lupascu, A., Ojetti, V., & Gasbarrini, G.
- Venue
- Digestive Diseases
- Publisher
- S. Karger AG
- Published
- 2007
- Volume
- 25
- Issue
- 3
- Pages
- 237-240
- ISSN
- 0257-2753 (ISSN-L)
- 1421-9875
- OpenAlex
- W1967438011
- Cited by
- 159
- References
- 2
- FWCI
- 6.41
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.